Supporting weight management during COVID-19

Conditions

Overweight and Obesity Nutritional, Metabolic, Endocrine Obesity

Mueller J, Richards R, Jones RA, Whittle F, Woolston J, Stubbings M, Sharp SJ, Griffin SJ, Bostock J, Hughes CA, Hill AJ, Boothby CE, Ahern AL.

2022-11-119 citations

10.1038/s41366-022-01232-x

Participants' experiences of mental health during a COVID-19 tailored ACT-based behavioural weight management intervention: a qualitative study

Rebecca A. Jones, Rebecca Richards, Roshni Palat, Carly A. Hughes, Andrew J. Hill et al. (9 authors)

International Journal of Qualitative Studies on Health and Well-Being2022-09-133 citations

10.1080/17482631.2022.2123093

Supporting Weight Management during COVID-19: A Randomized Controlled Trial of a Web-Based, ACT-Based, Guided Self-Help Intervention

Julia Mueller, Rebecca Richards, Rebecca A. Jones, Fiona Whittle, Jennifer Woolston et al. (12 authors)

Obesity Facts2022-01-0119 citations

10.1159/000524031

Interventions

Current intervention as of 15/06/2021: Participants will be randomised to either the SWiM intervention or to a standard advice wait list control using a computer-generated sequence wit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults (Age = 18 years) 2. Overweight or obesity (BMI = 25kg/m²) 3. Good understanding of written English (materials are not suitable for non-English language speakers) 4. Willing to be randomised to either intervention and to complete outcome assessments online 5. Own a set of scales that they can weigh themselves with during the study

Exclusion criteria

Exclusion criteria: 1. Bariatric surgery in the last 2 years

Design outcomes

Primary

Measure	Time frame
Current primary outcome measure as of 15/06/2021: Self-reported weight (kg) at baseline and 4 and 12 months follow up _____ Previous primary outcome measure: Self-reported weight (kg) at baseline and 4 months	—

Secondary

Measure	Time frame
Current secondary outcome measures as of 15/06/2021: At baseline 4 months, and 12 months: 1. General health measured using the Patient Health Questionnaire 8-item (PHQ-8) 2. Anxiety measured using the Generalized Anxiety Disorder 7-item (GAD-7) scale 3. Stress measured using the Perceived Stress Scale (PSS-4) 4. Weight-related thoughts and feelings measured using the Acceptance and Action Questionnaire Weight-Related (Revised) (AAQW-R) 5. Eating behaviour measured using the Three-Factor Eating Questionnaire (TFEQ-R21) 6. Physical activity measured using the International Physical Activity Questionnaire (IPAQ ) 7. Health related quality of life measured using EQ-5D-L 8. Wellbeing measured using ICECAP-A 9. Website Usage (data analytics) 10. Demographics and intervention engagement _____ Previous secondary outcome measures: At baseline and 4 months: 1. General health measured using the Patient Health Questionnaire 8-item (PHQ-8) 2. Anxiety measured using the Generalized Anxiety Disorder 7-item (GAD-7) scale 3. Stress measured using the Perceived Stress Scale (PSS-4) 4. Weight-related thoughts and feelings measured using the Acceptance and Action Questionnaire Weight-Related (Revised) (AAQW-R) 5. Eating behaviour measured using the Three-Factor Eating Questionnaire (TFEQ-R21) 6. Physical activity measured using the International Physical Activity Questionnaire (IPAQ ) 7. Health related quality of life measured using EQ-5D-L 8. Wellbeing measured using ICECAP-A 9. Website Usage (data analytics) 10. Demographics and intervention engagement	—

Measure

Time frame

Current secondary outcome measures as of 15/06/2021: At baseline 4 months, and 12 months: 1. General health measured using the Patient Health Questionnaire 8-item (PHQ-8) 2. Anxiety measured using the Generalized Anxiety Disorder 7-item (GAD-7) scale 3. Stress measured using the Perceived Stress Scale (PSS-4) 4. Weight-related thoughts and feelings measured using the Acceptance and Action Questionnaire Weight-Related (Revised) (AAQW-R) 5. Eating behaviour measured using the Three-Factor Eating Questionnaire (TFEQ-R21) 6. Physical activity measured using the International Physical Activity Questionnaire (IPAQ ) 7. Health related quality of life measured using EQ-5D-L 8. Wellbeing measured using ICECAP-A 9. Website Usage (data analytics) 10. Demographics and intervention engagement _____ Previous secondary outcome measures: At baseline and 4 months: 1. General health measured using the Patient Health Questionnaire 8-item (PHQ-8) 2. Anxiety measured using the Generalized Anxiety Disorder 7-item (GAD-7) scale 3. Stress measured using the Perceived Stress Scale (PSS-4) 4. Weight-related thoughts and feelings measured using the Acceptance and Action Questionnaire Weight-Related (Revised) (AAQW-R) 5. Eating behaviour measured using the Three-Factor Eating Questionnaire (TFEQ-R21) 6. Physical activity measured using the International Physical Activity Questionnaire (IPAQ ) 7. Health related quality of life measured using EQ-5D-L 8. Wellbeing measured using ICECAP-A 9. Website Usage (data analytics) 10. Demographics and intervention engagement

—

Countries

England, United Kingdom

Contacts

Public ContactJenny Woolston

jenny.woolston@mrc-epid.cam.ac.uk+44 (0)1223 769204

Outcome results

None listed